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Abstract
Background: Proteogenomics is a promising approach for various tasks ranging from gene annotation to cancer
research. Databases for proteogenomic searches are often constructed by adding peptide sequences inferred from
genomic or transcriptomic evidence to reference protein sequences. Such inflation of databases has potential of
identifying novel peptides. However, it also raises concerns on sensitive and reliable peptide identification. Spurious
peptides included in target databases may result in underestimated false discovery rate (FDR). On the other hand,
inflation of decoy databases could decrease the sensitivity of peptide identification due to the increased number of
high-scoring random hits. Although several studies have addressed these issues, widely applicable guidelines for
sensitive and reliable proteogenomic search have hardly been available.
Results: To systematically evaluate the effect of database inflation in proteogenomic searches, we constructed a
variety of real and simulated proteogenomic databases for yeast and human tandem mass spectrometry (MS/MS)
data, respectively. Against these databases, we tested two popular database search tools with various approaches
to search result validation: the target-decoy search strategy (with and without a refined scoring-metric) and a
mixture model-based method. The effect of separate filtering of known and novel peptides was also examined. The
results from real and simulated proteogenomic searches confirmed that separate filtering increases the sensitivity
and reliability in proteogenomic search. However, no one method consistently identified the largest (or the
smallest) number of novel peptides from real proteogenomic searches.
Conclusions: We propose to use a set of search result validation methods with separate filtering, for sensitive and
reliable identification of peptides in proteogenomic search.
Keywords: False discovery rate, Proteogenomic search, Separate false discovery rate analysis, Simulation, Target-
decoy approach, Model-based approach
Background
Proteogenomic search [1], i.e., searching tandem mass
spectrometry (MS/MS) spectra against an integrated
database consisting of reference proteins as well as
protein sequences derived from genomic or transcrip-
tomic evidence or hypotheses, is useful for identifying
novel or sample-specific peptides. Typical approaches
to the construction of proteogenomic databases in-
clude 6-frame translation of genome [2, 3] and
extracting splicing information from RNA sequencing
(RNA-seq) data [4–7]. In 6-frame translation of gen-
ome, peptide sequences are generated using each of
the six possible frames. From the extracted splicing in-
formation, novel splice-junction peptide sequences
could be obtained. These genomic or transcriptomic
information sources are essential for identifying novel
peptides, of which sequences are not contained in ref-
erence protein databases such as RefSeq [8] and
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UniProtKB [9]. Thus, proteogenomic search has been
applied to various tasks such as discovering novel
protein-coding regions [2, 10, 11], validation of gene
annotation [12–15], and studying disease mechanisms
for personalized diagnosis and treatments [16–18].
However, there are a number of challenges for proteo-
genomic search. Proteogenomic databases can be an
order of magnitude larger than reference protein data-
bases. For example, Woo and colleagues [6] constructed
a 6-frame translation (102 MB) and a splice graph
(410 MB) databases for Caenorhabditis elegans, which
were respectively 7 and 28 times of a C. elegans refer-
ence protein database from UniProtKB. The increased
size of proteogenomic databases demands a larger
amount of computational resources, resulting in longer
analysis time compared to the conventional proteomic
database search.
Moreover, such inflation of proteogenomic databases
makes it hard to apply widely used methods for control-
ling false discovery rates (FDRs) in peptide identification.
In proteomic database search, the FDR of a search result
is usually estimated by the target-decoy approach [19–21],
in which a decoy database–consisting of reversed or shuf-
fled version of the target protein database–is used. An in-
flated target database for proteogenomic search contains a
large number of spurious peptide sequences. For example,
most of the peptide sequences obtained from 6-frame
translation of a genome are not likely to be produced in
vivo or in vitro. In this regard, the FDR in proteogenomic
search is prone to underestimation, because random hits
to the spurious peptide sequences are considered as
target hits and their numbers are not negligible when
the database inflation is significant. Furthermore, the
size of decoy databases for proteogenomic search can
be significantly larger than the size of decoy databases
for conventional proteomic database search. An in-
flated decoy database could decrease the sensitivity of
peptide identification at the same FDR, because the
number of high-scoring decoy hits increases as the
size of decoy database increases.
Since the early stage of proteogenomics, it has been
well noted that proteogenomic searches would produce
more erroneous identifications than proteomic database
searches due to their database sizes [1, 22, 23]. Blakeley
and colleagues [24] showed that database choice is an
influencing factor on FDR estimation. They proposed to
limit database size for an improved FDR estimation in
the target-decoy approach. Krug and colleagues [25]
showed that FDRs in proteogenomic search could be
substantially underestimated, by using a 6-frame trans-
lated Escherichia coli genome. However, reliable and
sensitive peptide identification methods applicable to
various proteogenomic databases for organisms with
still-evolving genomic information are still not available.
To systematically evaluate the effect of database infla-
tion in proteogenomic search on peptide identification,
we generated a set of simulated and real proteogenomic
databases. Proteogenomic databases of varying sizes
were simulated by adding decoy peptide sequences to
reference protein databases. As real proteogenomic data-
bases, 6-frame translated versions of the yeast and the
human reference genomes and a splice graph database,
constructed from a human RNA-seq data set, were used.
A set of yeast and human MS/MS spectra were respect-
ively searched against the simulated and real proteoge-
nomic databases using two widely-used database search
tools, i.e., X!Tandem [26] and Comet [27]. To validate
the search results, the target-decoy search strategy [19,
21] and a mixture model-based method [28] were used
and compared. The target-decoy search strategy was also
tested with a refined scoring-metric calculated by the
self-boosted Percolator [29]. The mixture model-based
method assumes a mixture of score distributions for cor-
rect and incorrect peptide identifications. On the con-
trary, the other methods require minimal distributional
assumptions on peptide-spectrum match (PSM) scores.
Additionally, we examined the effect of separate filtering
of known and novel peptides with each of these
methods. The separate filtering method has been sug-
gested for proteogenomic search, considering the differ-
ence in the probability of identifying known and novel
peptides [1]. Our evaluation and comparison results of
various peptide identification approaches applied to vari-
ous proteogenomic databases provide insight into pep-
tide identifications in proteogenomics.
Methods
MS/MS data set
We used a yeast MS/MS data set generated and studied
by Joo and colleagues [30]. Briefly, the data set was ob-
tained from a yeast cell lysate, which was digested by
trypsin and then separated by MudPIT [31]. For the
MS/MS analysis, an LTQ-Orbitrap hybrid mass spec-
trometer was used. The yeast data set contained 63,031
MS/MS scans. We also used a human MS/MS data set
generated from a human gastric tissue sample. The tis-
sue sample was obtained from a Korean gastric cancer
patient, who signed internal review board (IRB)-ap-
proved informed consents. The human sample was
digested by trypsin and analyzed using a quadrupole
orbitrap mass spectrometer (Q Exactive, Thermo Scien-
tific, Bremen, Germany) coupled with a dual online ul-
trahigh pressure liquid chromatography system (see
Additional file 1: Supplementary methods for details on
sample preparation and liquid chromatography (LC)-
MS/MS experiments). The resulting data set contained
139,629 MS/MS spectra.
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Databases consisting of reference protein sequences
A yeast “target” protein database (1Ty), including 179 com-
mon contaminants and 6619 S. cerevisiae proteins down-
loaded from Swiss-Prot (07/2012), was constructed. The
total length of protein sequences in 1Ty was 3,062,279
amino acid (AA). A human target protein database (1Th),
containing UniProt human protein sequences (05/2013;
90,191 entries) and 179 common contaminants, was built.
The total length of protein sequences in 1Th was
35,856,033 AA. For simulated proteogenomic database
construction and FDR estimation (see Database construc-
tion for simulated proteogenomic search and Database
search and validation of search result), we used decoy data-
bases 1Dy and 1Dh, which were constructed by ‘pseudo-re-
versing’ [19] or ‘pseudo-shuffling’ the protein sequences in
1Ty and 1Th, respectively. To construct the decoy data-
bases, all the fully-tryptic peptides (with maximum missed
cleavage value of two) from the target protein databases
were extracted. Then, each of the extracted peptides was
reversed (pseudo-reversing) or randomly permuted
(pseudo-shuffling), preserving the length and the amino
acid composition of the original peptide. By modeling the
null hypothesis (i.e., incorrect PSM), decoy databases can
be used for p-value calculation and FDR estimation in pep-
tide identification [32].
Database construction for real proteogenomic search
Two types of real proteogenomic target databases were
used in the experiments: 6-frame translation databases for
yeast (6FTTy) and human (6FTTh) as well as a splice graph
database for human (SGTh). 6FTTy was constructed by 6-
frame translation of the yeast whole-genome sequences
(04/2014) downloaded from http://downloads.yeastgen-
ome.org/sequence/S288C_reference/chromosomes/fasta/.
6FTTh was generated based on 6-frame translation of the
human reference genome (hg19) downloaded from ftp://
ftp.ensembl.org/pub/release-71/fasta/homo_sapiens/dna/.
Both 6FTTy and 6FTTh were constructed using Cancer
Proteogenomics Tools developed by Woo and colleagues
[6] (downloaded from http://proteomics.ucsd.edu/software-
tools/splicedb-splice-graph-proteomics-tools/). It translates
regions in genome, between start and stop codons, and ig-
nores any splicing events. The length of proteins generated
by the tool is usually shorter than the length of reference
proteins. In total, 6FTTy contained 114,386 proteins, corre-
sponding to 2,010,708 fully-tryptic unique peptides (with
minimum length of eight AA and maximum missed cleav-
age value of 2). Among the 688,452 fully-tryptic peptides in
1Ty, 677,777 (98.4%) existed in 6FTTy. The number of
proteins in 6FTTh was 34,041,059, corresponding to
389,586,415 fully-tryptic unique peptides (with minimum
length of eight AA and maximum missed cleavage value of
2). Among the 3,118,351 fully-tryptic peptides in 1Th,
1,851,052 (59.4%) were contained in 6FTTh.
SGTh was constructed using an RNA-seq data set ob-
tained from the same tissue sample, used for generating
the human MS/MS data set (see MS/MS data set). The
RNA-seq data set (binary sequence alignment/map
(BAM) file) contained 41,353,547 reads mapped onto
the human reference genome (hg19). A splice graph, of
which nodes and edges respectively denote exons and
splice junctions, was built using the read mapping infor-
mation in the RNA-seq data set. From the splice graph,
protein sequences (i.e., splice graph targets) for database
search were extracted. We used Cancer Proteogenomics
Tools for constructing SGTh as in the studies by Woo
and colleagues [6] (see Additional file 1: Supplementary
methods for details on the RNA-seq analysis and splice
graph database construction). SGTh included 264,426
splice graph targets and 90,370 entries from 1Th. Decoy
databases for the three target proteogenomic databases
were created by pseudo-reversing (see Databases consist-
ing of reference protein sequences) and are denoted as
6FTDy, 6FTDh, and SGDh, respectively.
Database construction for simulated proteogenomic
search
We assumed that the majority of the newly added pep-
tide sequences to 6-frame translation and splice graph
databases, apart from reference protein sequences, are
not real target sequences but random sequences. For ex-
ample, the proportion of novel peptides identified from
a recent proteogenomic search [7] was 0.8% of the total
peptides identified, although the size of proteogenomic
database was more than 60 times larger than that of the
reference protein database. To test our hypothesis, we
constructed simulated proteogenomic databases contain-
ing varying numbers of “simulated novel” proteins,
which were generated by the decoy database generation
methods (see Databases consisting of reference protein
sequences).
A simulated proteogenomic target database for yeast,
1TnDy, was constructed by combining 1Ty and a decoy
database, nDy, of which size is n times larger than the size
of 1Ty. To build nDy, one pseudo-reversed version of 1Ty,
and (n – 1) pseudo-shuffled versions of 1Ty were generated
and merged. For example, 1T5Dy consisted of 1Ty, 1Dy
(pseudo-reversed), and 4Dy (pseudo-shuffled). When simu-
lating proteogenomic search with target-decoy approaches,
the decoy database for 1TnDy was constructed by combin-
ing (n + 1) pseudo-shuffled versions of 1Ty, and was de-
noted as (n + 1)Dy. Then, a search was performed against
‘1TnDy + (n + 1)Dy’. For example, the yeast MS/MS data set
was searched against ‘1T5Dy + 6Dy’, where 1T5Dy and 6Dy
respectively correspond to a simulated target proteoge-
nomic database and a same-sized decoy database. The same
procedure was used for simulating proteogenomic search
for human. Additional file 2: Figure S1 illustrates the entire
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workflow of simulated proteogenomic database construc-
tion. In the experiments, we used 1, 2, and 5 for the values
of n to evaluate the effect of database inflation. Tables 1
and 2 summarize the size of the databases containing refer-
ence protein sequences as well as the real and simulated
proteogenomic databases used in our experiments.
The pseudo-shuffling method could introduce an extra
level of redundancy into decoy databases by producing
multiple peptides of a same sequence. This can be espe-
cially problematic in simulated proteogenomic search,
where a large-sized decoy database is generated by
pseudo-shuffling. Thus, we checked the level of redun-
dancy in the decoy databases used in our experiments
for simulated proteogenomic search. The proportion of
redundant peptides in the generated decoy databases
was less than 0.74 and 1.50% for yeast and human, re-
spectively (see Additional file 3: Table S1). These num-
bers are still smaller than the proportion of redundant
peptides in the reference protein databases, 1Ty and
1Th: 2.24 and 59.62%, respectively.
Database search and validation of search result
Two database search tools, X!Tandem [26] and Comet
[27], were used in the experiments. For the yeast MS/
MS data set, 3 Da peptide mass tolerance, 1 Da MS/MS
mass tolerance, and semi-tryptic option, were assigned
to the two search tools. The human MS/MS data set
was also searched by X!Tandem and Comet with 15 ppm
parent mass tolerance, 0.03 Da fragment mass tolerance,
and fully-tryptic option. For both data sets, one fixed
modification at Cys (Carbamidomethyl, +57.02146) and
one variable modification at Met (Oxidation, +15.99492)
were allowed.
We applied the target-decoy search strategy (TD) to
search result validation. Only the PSMs with minimum
peptide length of eight AA were validated based on the
PSM score: E-value for X!Tandem and XCorr for Comet.
The FDR was estimated by ND/NT, where ND and NT re-
spectively denote the number of decoy hits and the
number of target hits above the score threshold. Further-
more, the effect of scores used in TD was tested by the
self-boosted Percolator (BP) [29]. BP is an improved ver-
sion of Percolator [33], in which the sensitiveness of Per-
colator to initial PSM ranking decreases by repeatedly
applying the semi-supervised learning procedure with
different labeling of training examples. We also exam-
ined a mixture model-based method (MB) for identifying
high-confidence peptides. PeptideProphet [28] (trans-
proteomic pipeline (TPP) version 4.7.1) in semi-
parametric mode (with minimum peptide length of eight
AA, minimum peptide probability of 0, and the accurate
mass binning option) was applied to FDR estimation. As
recommended, the Gumbel distribution and the Gauss-
ian distribution were chosen for modeling the discrimin-
ant function values for incorrect PSMs in X!Tandem and
Comet, respectively. After a mixture model was fitted to






fSi : Si≥tg ; ð1Þ
where Si and PEPi respectively denote the discriminant
function value and the posterior error probability of the ith
PSM, and the denominator means the number of PSMs
whose discriminant function values are equal to or larger
than the cutoff value t. The discriminant function calcu-
lates a summarized quality-score for PSMs based on mul-
tiple features including search score, and is optimized for
each search engine [34]. The posterior error probability of
the ith PSM—the probability that it is incorrect given its
discriminant function value Si —was computed from the
learned mixture model.
The three methods, TD, BP, and MB, were also ap-
plied to separate filtering of known and novel (or simu-
lated novel) peptides (SepTD, SepBP, and SepMB; see
Additional file 4: Figure S2). In SepTD, PSMs were di-
vided into two groups—known and novel (or simulated
novel)—after database search. Then, each PSM group
Table 1 Size of proteomic, simulated proteogenomic, and real
proteogenomic databases for yeast
Database (target + decoy) # Target (AA) # Decoy (AA)
Proteomic 1Ty + 1Dy 3,062,279 3,062,279
Simulated proteogenomic 1T1Dy + 2Dy 6,124,558 6,124,558
1T2Dy + 3Dy 9,186,837 9,186,837
1T5Dy + 6Dy 18,373,674 18,373,674
Real proteogenomic 6FTTy + 6FTDy 9,654,965 9,654,965
Database sizes are measured by total length (AA) of contained peptides. 1Ty:
yeast reference protein database. nDy: decoy database of which size is n times
of 1Ty. 6FTTy: proteogenomic database constructed by 6-frame translation of
yeast genome. 6FTDy: decoy database for 6FTTy
Table 2 Size of proteomic, simulated proteogenomic, and real
proteogenomic databases for human
Database (target + decoy) # Target (AA) # Decoy (AA)
Proteomic 1Th + 1Dh 35,856,033 35,856,033
Simulated proteogenomic 1T1Dh + 2Dh 71,712,066 71,712,066
1T2Dh + 3Dh 107,568,099 107,568,099
1T5Dh + 6Dh 215,136,198 215,136,198
Real proteogenomic 6FTTh + 6FTDh 2,136,069,837 2,136,069,837
SGTh + SGDh 123,364,545 123,364,545
Database sizes are measured by total length (AA) of contained peptides. 1Th:
human reference protein database. nDh: decoy database of which size is n
times of 1Th. 6FTTh: proteogenomic database constructed by 6-frame transla-
tion of human genome. 6FTDh: decoy database for 6FTTh. SGTh: proteoge-
nomic database constructed by splicing information from human RNA
sequencing data. SGDh: decoy database for SGTh
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was separately filtered by TD. For the semi-supervised
machine learning in SepBP or SepMB, the PSMs of
both reference (known) and non-reference (novel or
simulated novel) protein sequences were used together
as in BP or MB, because it was not possible to train a
separate support vector machine or fit a separate mix-
ture model using only the novel (or simulated novel)
PSMs. After the machine learning step, PSMs were di-
vided into known and novel (or simulated novel)
groups. Then, each group was separately filtered as fol-
lows. In SepBP, the PSMs of each group were separately
sorted by the recalibrated score from BP, and filtered by
estimating the FDR as ND/NT. In SepMB, the PSMs of
each group were separately sorted by (1 – posterior
error probability), and filtered by estimating the FDR as
ND/NT. In the experiments, 1% FDR cut-off was used
for high-confidence peptide identification. We calcu-
lated peptide-level FDRs by considering only the
highest-scoring PSM per peptide.
Results and Discussion
Comparison between simulated and real proteogenomic
search results
To test the effectiveness of simulation experiments, pep-
tide identification results were compared between the fol-
lowing simulated and real proteogenomic database pairs
of similar sizes: ‘1T2Dy + 3Dy’ (9,186,837 + 9,186,837 AA)
and ‘6FTTy + 6FTDy’ (9,654,965 + 9,654,965 AA) for yeast,
and ‘1T2Dh + 3Dh’ (107,568,099 + 107,568,099 AA) and
‘SGTh + SGDh’ (123,364,545 + 123,364,545 AA) for human
(see Tables 1 and 2).
First, we examined the proportion of peptides from
reference protein sequences (i.e., known peptides)
among the peptide identification results, because we hy-
pothesized that a substantial amount of peptides added
to reference protein sequences for proteogenomic search
would not be real target but random sequences (see
Database construction for simulated proteogenomic
search). Figure 1 shows the number of known and novel
(or simulated novel) peptides at 1% FDR identified from
the search results using X!Tandem. As expected, most
peptides from the simulated and the real proteogenomic
searches were known peptides: more than 98.76% for
‘1T2Dy + 3Dy’, 96.64% for ‘6FTTy + 6FTDy’, 99.36% for
‘1T2Dh + 3Dh’, and 99.14% for ‘SGTh + SGDh’. The re-
sults using Comet were also similar (Additional file 5:
Figure S3).
The total number of known and novel (or simulated
novel) peptides identified from the simulated and real pro-
teogenomic databases of similar sizes was also similar in
most cases. For yeast, the difference was from 51 to 556
(corresponding to 0.95 to 8.99% of the peptides identified
from ‘6FTTy + 6FTDy’) when X!Tandem was used
(Fig. 1(a)). The difference in the results for yeast obtained
using Comet was also small (from 0.90 to 4.41%), except
for the results validated by SepTD and SepBP, in which
the difference was 32.63 and 15.51% of the number of
peptides identified from ‘6FTTy + 6FTDy’, respectively
Fig. 1 Comparison of peptide identification results between a pair of simulated and real proteogenomic databases of similar sizes for yeast
(1T2Dy and 6FTTy) (a) and human (1T2Dh and SGTh) (b). Database searches were performed using X!Tandem. The number of peptides at 1% FDR
is shown. TD: target-decoy search strategy. BP: TD with a refined scoring-metric calculated by the self-boosted Percolator. MB: mixture model-
based method. SepTD, SepBP, and SepMB denote separate filtering of known and novel (or simulated novel) peptides with TD, BP, and MB, re-
spectively. The blue bars and numbers in white denote the number of known peptides. The red bars and numbers in red denote the number of
novel (or simulated novel) peptides
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(Additional file 5: Figure S3(a)). In these two cases, the in-
crease in the number of identified peptides by separate fil-
tering of known and novel (or simulated novel) peptides
was much larger for ‘6FTTy + 6FTDy’ than for ‘1T2Dy +
3Dy’. For the human data set, the difference in the number
of identified peptides was 9.38 to 19.02% (for X!Tandem)
and 2.80 to 13.86% (for Comet) of the number of peptides
identified from ‘SGTh + SGDh’ (Fig. 1(b) and Additional
file 5: Figure S3(b)). It must be noted that the size differ-
ence between the simulated and real proteogenomic data-
bases was 4.85% (‘1T2Dy + 3Dy’ and ‘6FTTy + 6FTDy’) and
12.80% (‘1T2Dh + 3Dh’ and ‘SGTh + SGDh’).
Thus, we observed that proteogenomic search against
simulated and real proteogenomic databases of similar
sizes produced similar results with regard to the propor-
tion of known peptides identified from reference protein
sequences as well as the total number of identified pep-
tides at the same FDR in most cases. These results sug-
gest that we could use simulated proteogenomic
databases for quantitatively examining the effect of data-
base inflation on the sensitivity and reliability of peptide
identifications.
Sensitivity and reliability in simulated proteogenomic
search
We investigated the effect of database inflation in pro-
teogenomic search on sensitivity and reliability of pep-
tide identification by using simulated target-protein
databases for proteogenomic search, comprised of refer-
ence (1Ty or 1Th) and simulated novel (nDy or nDh) pro-
tein sequences. Here, sensitivity denotes the number of
identified peptides from target protein databases. As
decoy databases for simulated proteogenomic search, (n
+ 1)Dy or (n + 1)Dh was used (see Database construction
for simulated proteogenomic search). Figures 2 and 3
show the peptide identification results (charge 2+ and
FDR 1%) using X!Tandem from simulated proteoge-
nomic databases of varying sizes (n = 0, 1, 2, and 5) for
yeast and human, respectively. Overall, the number of
peptides identified by using TD, BP, and MB decreased
as the number of added decoy-peptides to the target
database increased in most cases. For example, the num-
ber of peptides identified by search against ‘1TnDy + (n
+ 1)Dy’ (FDR 1% controlled by TD) decreased from 3759
to 3434 as n increased from 0 to 5 (Fig. 2(a)). When n
equals 5, the decrease rate in the number of identified
peptides was 8.65% (TD for yeast), 7.48% (BP for yeast),
4.14% (MB for yeast), 21.95% (TD for human), 10.07%
(BP for human), and 20.91% (MB for human) (Figs. 2(a),
(c), (e), 3(a), (c), and (e)). Thus, it seems that the inflated
database could substantially deteriorate the sensitivity of
proteogenomic search when known and simulated novel
peptides are filtered together. However, the effect of
database inflation was substantially attenuated by
separate filtering of known and simulated novel peptides.
The number of peptides identified by using SepTD or
SepMB did not decrease while the database size increased
(Figs. 2(b), (f), 3(b), and (f)). The decrease rate in the num-
ber of peptides identified using SepBP was smaller than the
decrease rate in the results using BP (Figs. 2(c), (d), 3(c),
and (d)). From the results on 3+ peptides (Additional file 6:
Figure S4 and Additional file 7: Figure S5) and the results
obtained using Comet (Additional file 8: Figure S6,
Additional file 9: Figure S7, Additional file 10: Figure S8,
and Additional file 11: Figure S9), we observed similar ten-
dencies. Therefore, it is essential to filter known and novel
peptides separately for high sensitivities in proteogenomic
search.
Among the three separate filtering methods, SepBP iden-
tified the largest number of peptides from the search results
using X!Tandem (Figs. 2 and 3; Additional file 6: Figure S4
and Additional file 7: Figure S5). In most cases, SepBP and
SepMB identified larger numbers of peptides than SepTD
from the search results using Comet (Additional file 8:
Figure S6, Additional file 9: Figure S7, Additional file 10:
Figure S8, and Additional file 11: Figure S9). Thus, machine
learning-based methods for search result validation seem to
improve the sensitivity in proteogenomic search.
We counted the number of simulated novel peptides
identified from nDy or nDh, because they are highly
probable to be false positives. In most cases, the number
of identified simulated-novel peptides increased as n
increased (Figs. 2 and 3; Additional file 6: Figure S4,
Additional file 7: Figure S5, Additional file 8: Figure S6,
Additional file 9: Figure S7, Additional file 10: Figure S8,
and Additional file 11: Figure S9). Thus, the database in-
flation in proteogenomic search could also deteriorate
the reliability in peptide identification regardless of
search result validation methods. However, the number
of simulated novel peptides identified by TD, BP, or MB
was always much larger than SepTD, SepBP, or SepMB,
suggesting that separate filtering of known and novel
peptides is also essential for improving the reliability in
proteogenomic search. Among the three separate filter-
ing methods, SepBP identified the largest number of
simulated novel peptides in most cases. SepTD was the
most conservative for simulated novel peptide
identification.
Sensitivity and reliability in real proteogenomic search
We examined and compared the six methods for search
result validation using the three real proteogenomic da-
tabases: ‘6FTTy + 6FTDy’ for yeast, ‘6FTTh + 6FTDh’ and
‘SGTh + SGDh’ for human (see Database construction
for real proteogenomic search). Tables 3 and 4 respect-
ively show the numbers of peptides with charge 2+ and
with charge 3+ at 1% FDR, identified from the real pro-
teogenomic search using X!Tandem. We observed that
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separate filtering of known and novel peptides consist-
ently increased the number of identified peptides as in
the results from simulated proteogenomic search.
Moreover, the number of identified known-peptides in-
creased, but the number of identified novel-peptides
decreased by separate filtering (SepTD, SepBP, or
SepMB). For example, the numbers of known and novel
peptides (charge 2+) identified by TD from the search
against ‘6FTTh + 6FTDh’ were 4115 and 62, respectively
(Table 3). From the same search result, SepTD identi-
fied 53.97% more known-peptides (6336) and 82.26%
less novel-peptides (11). On average, 26.23% more
known- and 89.18% less novel-peptides were identified
by the three separate filtering methods (Tables 3 and
4). Considering the fact that novel peptides are more
probable to be false positives than known ones, SepTD,
SepBP, and SepMB seem to increase the sensitivity in
the identification of known peptides while increasing
the reliability in the identification of novel peptides.
The results from the real proteogenomic searches using
Comet were also similar (Additional file 12: Table S2
and Additional file 13: Table S3).
We compared the three separate filtering meth-
ods—SepTD, SepBP, and SepMB—regarding novel
peptide identification. In Table 3, SepMB identified
the smallest number of novel peptides with charge 2+
from the search against ‘6FTTh + 6FTDh’ using X!Tan-
dem. However, the same method identified the largest
Fig. 2 Peptide identification results from search against simulated proteogenomic databases for yeast (1TnDy) using X!Tandem (n = 0, 1, 2, and 5).
The number of peptides with charge 2+ at 1% FDR is shown. TD: target-decoy search strategy (a). BP: TD with a refined scoring-metric calculated
by the self-boosted Percolator (c). MB: mixture model-based method (e). SepTD (b), SepBP (d), and SepMB (f) denote separate filtering of known
and simulated novel peptides with TD, BP, and MB, respectively. The blue bars and numbers in white denote the number of known peptides. The
red bars and numbers in red denote the number of simulated novel peptides
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number of novel peptides with the same charge, from
the search against ‘SGTh + SGDh’ using the same data-
base search tool. SepMB also identified the largest
number of novel peptides (charge 2+) from the search
against ‘6FTTh + 6FTDh’ using Comet (Additional file
12: Table S2). Therefore, there does not seem to exist
one specific method, which is the most (or the least)
conservative for identifying novel peptides from real
proteogenomic search, among the three filtering
methods. In many cases, SepTD, SepBP, and SepMB
identified similar numbers of novel peptides from the
three real proteogenomic databases. However, SepBP
identified much larger numbers (>50 more) of novel
peptides with charge 2+ than SepTD and SepMB, from
the searches against ‘6FTTy + 6FTDy’ and ‘6FTTh +
6FTDh’ using X!Tandem (Table 3). Thus, SepBP could
produce different results compared with the other two
methods in novel peptide identification from proteo-
genomic search.
We also compared the novel peptides identified at
1% FDR by SepTD, SepBP, and SepMB. Figure 4 and
Additional file 14: Figure S10 show the comparison re-
sults for X!Tandem and Comet, respectively. In most
cases, the number of novel peptides commonly identi-
fied by the three filtering methods was small. The
three methods commonly identified one novel-peptide
(charge 3+) from the search against ‘6FTTy + 6FTDy’
(see Fig. 4(d) and Additional file 14: Figure S10(d)).
Except for this case, the proportion of commonly-
identified novel peptides was less than 30%, suggesting
that the sensitivity in novel peptide identification
could be improved by combining results from multiple
Fig. 3 Peptide identification results from search against simulated proteogenomic databases for human (1TnDh) using X!Tandem (n= 0, 1, 2, and 5). The
number of peptides with charge 2+ at 1% FDR is shown. TD: target-decoy search strategy (a). BP: TD with a refined scoring-metric calculated by the self-
boosted Percolator (c). MB: mixture model-based method (e). SepTD (b), SepBP (d), and SepMB (f) denote separate filtering of known and simulated novel
peptides with TD, BP, and MB, respectively. The blue bars and numbers in white denote the number of known peptides. The red bars and numbers in red de-
note the number of simulated novel peptides
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methods for separate filtering of known and novel
peptides.
With regard to the identification of known peptides from
proteogenomic search, SepBP identified larger numbers of
peptides than SepTD and SepMB in most cases. From the
search results obtained using Comet, SepBP identified 6.23
to 65.82% more known-peptides compared to SepTD or
SepMB (Additional file 12: Table S2 and Additional file 13:
Table S3). Only for the human data set searched against
‘6FTTh + 6FTDh’ using X!Tandem, SepBP identified a
smaller number (5950) of known peptides (charge 2+) com-
pared with SepTD (6336) and SepMB (6180), respectively
(Table 3). In many cases, SepTD and SepMB identified
similar numbers of known peptides, except for the case of
identifying known peptides (charge 3+) from the search
against ‘6FTTy + 6FTDy’ using X!Tandem, where SepMB
identified 21.24% more peptides than SepTD (Table 4).
Besides the six search-result validation methods, we
tested the two-stage FDR method [7] against ‘SGTh +
SGDh’. In the two-stage FDR method for proteoge-
nomic search, only the spectra, not matched to refer-
ence protein sequences with a sufficient level of
confidence, were searched against proteogenomic da-
tabases (see Additional file 1: Supplementary methods
for more detailed description on the two-stage FDR
method). Additional file 15: Table S4 compares the
peptide identification results among TD, SepTD, and
the two-stage FDR method. Similar to the separate fil-
tering methods, the two-stage FDR method increased
the number of identified known-peptides while de-
creasing the number of identified novel-peptides.
SepTD and the two-stage FDR method identified simi-
lar numbers of novel peptides.
Conclusions
Proteogenomic searches, originally suggested for gene an-
notation and validation, are now becoming a routine tool
for many tasks including proteogenomic characterization
of tumors. Since proteogenomic databases are inflated
with a large number of spurious peptide sequences, it is
important to accurately estimate the effect of such infla-
tion on sensitive and reliable peptide identification. We
evaluated the effect of database inflation in proteogenomic
search using various simulated and real proteogenomic
databases. Two popular database search tools with six ap-
proaches to search result validation were tested. First, we
showed that the number of peptides identified from simu-
lated and real proteogenomic databases of similar sizes is
also similar, confirming the effectiveness of using simu-
lated proteogenomic databases in estimating sensitivity
and reliability of various search and validation strategies.
Table 3 Number of peptides with charge 2+ at 1% FDR identified from search against real proteogenomic databases using
X!Tandem
Database (target + decoy) TD BP MB SepTD SepBP SepMB
6FTTy + 6FTDy Total 3,626 4,281 3,807 3,942 4,515 3,870
Known 3,603 4,106 3,781 3,942 4,443 3,870
Novel 23 175 26 0 72 0
6FTTh + 6FTDh Total 4,177 5,620 4,813 6,347 6,018 6,188
Known 4,115 5,316 4,765 6,336 5,950 6,180
Novel 62 304 48 11 68 8
SGTh + SGDh Total 8,034 11,059 9,152 8,957 11,150 9,552
Known 7,966 11,016 9,087 8,940 11,136 9,531
Novel 68 43 65 17 14 21
6FTTy (or 6FTTh): proteogenomic database constructed by 6-frame translation of yeast (or human) genome. 6FTDy (or 6FTDh): decoy database for 6FTTy (or 6FTTh).
SGTh: proteogenomic database constructed by splicing information obtained from human RNA sequencing data. SGDh: decoy database for SGTh. TD: target-decoy
strategy. BP: target-decoy strategy using a refined score calculated by the self-boosted Percolator. MB: mixture model-based method. SepTD, SepBP, and SepMB
denote separate filtering of known and novel peptides using TD, BP, and MB, respectively
Table 4 Number of peptides with charge 3+ at 1% FDR
identified from search against real proteogenomic databases
using X!Tandem
Database (target + decoy) TD BP MB SepTD SepBP SepMB
6FTTy + 6FTDy Total 1,705 3,452 2,403 2,054 4,072 2,490
Known 1,697 3,407 2,385 2,053 4,071 2,489
Novel 8 45 18 1 1 1
6FTTh + 6FTDh Total 1,436 3,001 1,022 2,363 3,055 2,356
Known 1,413 2,959 1,005 2,348 3,044 2,352
Novel 23 42 17 15 11 4
SGTh + SGDh Total 3,467 6,552 2,705 3,840 6,568 3,518
Known 3,433 6,526 2,680 3,836 6,562 3,511
Novel 34 26 25 4 6 7
6FTTy (or 6FTTh): proteogenomic database constructed by 6-frame translation
of yeast (or human) genome. 6FTDy (or 6FTDh): decoy database for 6FTTy (or
6FTTh). SGTh: proteogenomic database constructed by splicing information ob-
tained from human RNA sequencing data. SGDh: decoy database for SGTh. TD:
target-decoy strategy. BP: target-decoy strategy using a refined score calcu-
lated by the self-boosted Percolator. MB: mixture model-based method. SepTD,
SepBP, and SepMB denote separate filtering of known and novel peptides
using TD, BP, and MB, respectively
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Then, the relationship between the database size and the
number of identified peptides was examined using simu-
lated proteogenomic databases. When known and
simulated-novel peptides were filtered together, the num-
ber of peptides at the same FDR decreased as the (target
+ decoy) database size increased. However, the results
from separate filtering of known and simulated-novel pep-
tides were almost not influenced by changes in database
sizes. Moreover, the separate filtering methods effectively
removed most of the simulated-novel peptides, which are
highly likely to be false positives. Finally, the sensitivity
and reliability of real proteogenomic search was examined
using 6-frame translated versions of the yeast and the hu-
man genomes and a splice graph database constructed
using human RNA-seq data. As in the results from simu-
lated proteogenomic search, separate filtering of known
and novel peptides increased the number of identified
known-peptides while decreasing the number of identified
novel-peptides, compared with the methods which filter
known and novel peptides together. Therefore, separate
filtering of known and novel peptides is strongly recom-
mended for proteogenomic database search. Among the
three separate filtering methods, SepBP generally identi-
fied the largest number of peptides, suggesting that semi-
supervised machine learning could be effective in increas-
ing the sensitivity of proteogenomic search. In terms of
novel peptide identification, the three separate filtering
methods usually identified similar numbers of novel pep-
tides; however, no one method consistently identified the
largest (or the smallest) number of novel peptides.
Furthermore, the number of novel peptides commonly
identified by the three methods was not large, suggesting
that false negatives could be an issue even in novel peptide
identification. In order to reduce the false negatives, one
can apply multiple separate filtering methods to a proteo-
genomic search result and combine the novel peptides
identified by each method. As a conclusion, we propose to
use two or more methods for search result validation with
separate filtering of known and novel peptides, for maxi-
mizing the sensitivity and reliability in proteogenomic
search.
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